INBIOGEN Extraordinary General Meeting Approves Re-election of Inside Director Kang Ji-yeon and Appointment of Outside Director Seo Joong-seok and Auditor Park Jae-hong


  • INBIOGEN disclosed that at the extraordinary general meeting held on June 30, 2026, all three agenda items were approved as originally proposed: re-election of inside director Kang Ji-yeon, new appointment of outside director Seo Joong-seok, and new appointment of standing auditor Park Jae-hong.
  • The first agenda item on re-election of inside director Kang Ji-yeon passed with 79.4% approval based on total outstanding shares and 100% based on shares voted. The second item on outside director Seo Joong-seok recorded the same approval rates.
  • The third item on standing auditor Park Jae-hong passed with majority approval of attending shareholders due to electronic voting exemption from the one-fourth total shares requirement, with 99.9% approval based on shares voted.
  • [AI Summary]INBIOGEN completed a routine board restructuring through an extraordinary general meeting, but no direct impact on shareholder value such as capital changes or dividends was identified. This resolution is a procedural step in corporate governance and is considered neutral from an investment perspective.

KOSPI Filing Information


  • Result of Extraordinary General Meeting of Shareholders
  • Company: INBIOGEN (101140)
  • Submission: INBIOGEN CO.,Ltd
  • Under KRX KOSPI Market Division

  • Shares: 10,044,216
  • Price: 5,990 KRW
  • Market Cap: 60.2 B KRW